Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement

The End of Silicon Valley as We Know It?

IPO shows significant growth in healthcare industry

Amazon Genomics CLI is Open Source, UK Biobank’s Research Analysis Platform Live

Microsoft’s next moves: Biz dev and strategy leader Christopher Young is focusing on these key areas

Gathering Strength, Gathering Storms: The One Hundred Year Study on Artificial Intelligence (AI100) 2021 Study Panel Report

The Coming Age for Tech x Bio: The “Industrial Bio Complex”

AI drug discovery platform raises Series B funding

VC Firms Have Long Backed AI. Now, They Are Using It.

Ronald Cohen: “Mesurons l’impact comme on mesure les profits”